Dr Agarwals Eye Hospital Ltd.
| BSE: 526783 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE934C01018 |
| BSE 00:00 | 29 Jun | 613.00 |
-6.70 (-1.08%) |
OPEN
619.00 |
HIGH
619.00 |
LOW
613.00 |
| NSE 05:30 | 01 Jan | Dr Agarwals Eye Hospital Ltd |
| OPEN | 619.00 |
| PREVIOUS CLOSE | 619.70 |
| VOLUME | 92 |
| 52-Week high | 925.00 |
| 52-Week low | 380.70 |
| P/E | 11.95 |
| Mkt Cap.(Rs cr) | 288 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Dr Agarwals Eye Hospital Ltd. (DRAGARWALSEYE) - News Sector
-
Biocon Biologics bribery case: CBI moves HC challenging lower court verdict
7.55 pm | 28 Jun 2022 | Press Trust of India
The Delhi High Court has issued notices to the parties concerned and will hear the case on July 2
-
Glenmark acquires Wockhardt's key OTC brands in US for undisclosed sum
3.32 pm | 28 Jun 2022 | Business Standard
Deal includes approved ANDAs for famotidine tablets, used in treatment and prevention of ulcers stomach and intestinal ulcers
-
Aurobindo Pharma receives Sebi's warning letter over ongoing USFDA audit
5.54 pm | 27 Jun 2022 | Press Trust of India
The letter is in regards to certain disclosures made by the company on the ongoing USFDA audit of company's Unit-1 and observations made by the USFDA ...
-
Zomato, Dish TV, Biocon: Trading strategies for buzzing stocks of the day
12.45 pm | 27 Jun 2022 | Business Standard
Shares of Zomato face stiff resistance at Rs 78, while the downside support stays at Rs 60
-
Our Caribbean ops bring us close to US mkt: Narayana Health's Viren Shetty
4.19 pm | 26 Jun 2022 | Business Standard
In a Q&A, the executive vice-chairman of the hospital chain dwells on lessons from the pandemic, says hospital industry has always been dollar-exposed...
-
Dr Reddy's Laboratories eyes place among top five domestic pharma players
12.54 am | 25 Jun 2022 | Business Standard
The US would continue to remain an important geography, but the firm says it hopes to double its revenues from China and grow revenues five-fold in Br...
-
Ajanta Pharma extends fall, slips 2%; stock turned ex-bonus on Wednesday
12.56 pm | 23 Jun 2022 | Business Standard
The company had fixed June 23, 2022 as the record date for the bonus issue in the proportion of one equity share for every two equity shares held
-
Biocon slips 4% despite arm denying bribery charges
11.07 am | 22 Jun 2022 | Business Standard
At 10:26 AM, the stock of Biocon was down 3 per cent at Rs 316.10, as compared to 1 per cent decline in the S&P BSE Sensex
-
Gland Pharma rides high on valuation comfort, strong growth prospects
12.51 am | 22 Jun 2022 | Business Standard
Target prices post brokerage upgrades point to more upsides
-
Suven Life freezes at 20% upper circuit as board to mull rights issue
3.23 pm | 21 Jun 2022 | Business Standard
The stock had hit a 52-week low of Rs 62 on June 20, 2022, and has corrected 50 per cent from its record high level of Rs 124 touched on October 8, 20...
-
Stocks to Watch: Telecom, LIC Hsg Fin, KEC Intl, Suven Life, IIFL Finance
7.56 am | 21 Jun 2022 | Business Standard
Stocks to Watch Today: Indiabulls Housing Finance and RBL Bank are the two stocks in F&O ban period on Tuesday.
-
1 in 3 Nifty500 stocks are down 25% YTD; 15 have halved their 2022 gains
1.30 pm | 20 Jun 2022 | Business Standard
A total of four stocks -- Dhani Services, Brightcom Group, Indiabulls Real Estate and Solara Active Pharma Sciences -- have been butchered more than 6...
-
Glenmark drug for treating uncontrolled asthma gets Indian regulator's nod
12.35 am | 17 Jun 2022 | Business Standard
Company says treatment will be affordable and improve lung function of patients
-
Paytm, Zomato, Indiabulls Housing look oversold; can jump up to 25%
1.08 pm | 15 Jun 2022 | Business Standard
Among the beaten down mid- and small-cap stocks, Paytm and Zomato can provide some relief to investors, while stocks like Metropolis Healthcare and La...
-
No plans to exit business, says Metropolis Healthcare promoters
11.01 am | 14 Jun 2022 | Business Standard
"The company, its promoters and management team are committed to operating Metropolis Healthcare Ltd with the highest standards of medical science, st...
-
No plans to exit business, clarify Metropolis Healthcare promoters
10.53 am | 14 Jun 2022 | Business Standard
Metropolis Healthcare is continuously exploring various strategic options and investment
-
Metropolis tanks 27% in 1-mth on promoter stake sale buzz, latter clarifies
9.59 am | 14 Jun 2022 | Business Standard
The promoters of Metropolis Healthcare on Monday after market hours clarified that they have no intention to exit the business.
-
Stocks to Watch: Banks, Lupin, YES Bank, CG Electricals, Ujjivan SFB, Sugar
8.19 am | 9 Jun 2022 | Business Standard
Stocks to Watch Today: Sugar industry has requested the government that the additional 1 MT export order be given the mills, and not trader or exporte...
-
Tamil Nadu agency blacklists Abbott for five years for hiding information
1.07 am | 9 Jun 2022 | Business Standard
TNMSC Managing Director Deepak Jacob said the step was taken after a complaint from Paris Legal Cell in Chennai
-
Lupin receives tentative approval from USFDA to market Ivacaftor tablets
12.42 am | 9 Jun 2022 | Press Trust of India
The product is the generic equivalent of Vertex Pharmaceuticals' Kalydeco tablets, Lupin said in a statement
Quick Links for Dr Agarwals Eye Hospital:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
